동물 내분비 시장 규모, 점유율, 동향 분석 보고서 : 동물 유형별, 용도별, 투여 경로별, 지역별, 부문별 예측(2024-2030년)

Veterinary Endocrinology Market Growth & Trends:

The global veterinary endocrinology market size is expected to reach USD 480.28 million by 2030, registering a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Some key drivers fueling the market growth include increasing uptake of pet insurance, humanization of pets, improving diagnostic rates, and initiatives by key market players. In 2022, Dechra launched Zycortal- its desoxycorticosterone pivalate suspension for Addison's disease management for dogs in Brazil. This expanded its product portfolio.

Certain dog breeds exhibit a predisposition to various endocrine disorders, which significantly drives demand for veterinary endocrinology services and products. As per Embrace Pet Insurance for instance, some of the breeds that may be predisposed to hypothyroidism include Golden Retriever, Great Dane, Boxer, Cocker Spaniel, English Bulldog, and Doberman Pinscher. This predisposition stems from a combination of genetic factors and breed-specific physiological traits, making these breeds more susceptible to endocrine imbalances. Consequently, pet owners of these breeds are more vigilant about monitoring their pets' health and seek specialized veterinary care, including regular screenings, diagnostic tests, and tailored treatment plans, thereby fueling the demand for veterinary endocrinology services and products.

Another significant market driver is the growing awareness and emphasis on pet health and wellness among owners. With pets increasingly regarded as family members, owners are more willing to invest in comprehensive veterinary care to ensure the well-being of their animals. This includes regular health check-ups, preventive measures, and prompt treatment of any health issues, including endocrine disorders. The heightened awareness among pet owners leads to greater demand for specialized veterinary services, diagnostic tools, and therapeutic options tailored to manage endocrine conditions effectively. As disposable incomes rise and pet owners prioritize their pets' health and well-being, there is a corresponding increase in veterinary healthcare expenditure. This is also expected to propel the market growth.

Technological advancements and innovations in veterinary diagnostics, therapeutics, and treatment modalities have enhanced the capabilities of veterinary professionals in diagnosing and managing endocrine disorders in animals. Improved diagnostic tools, such as advanced imaging techniques and genetic testing, enable more accurate diagnosis, while innovative treatment options offer better outcomes for pets with endocrine conditions.

Veterinary Endocrinology Market Report Highlights:

• By animal type, the dogs segment dominated the market with a share of 61.2% in 2023. Other animals segment comprising horses is expected to grow at the fastest growth rate during the forecast period.
• The pancreatic disorders segment held the largest share of the market by application in 2023. The other disorders segment on the other hand is poised to grow the fastest CAGR from 2024 to 2030.
• By route of administration, oral segment dominated the market in 2023. Other routes segment comprising injectables is anticipated to grow at the fastest CAGR during the forecast period.
• The North American market attributed to the largest share of 40.3% of the total market by region in 2023. The market in Asia Pacific is anticipated to grow at the fastest CAGR from 2024 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Endocrinology Industry Outlook

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Pet Humanization
    • 3.2.1.2. Increasing medicalization rate
    • 3.2.1.3. Supportive R&D initiatives
    • 3.2.1.4. Increasing adoption of pet insurance
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of pet care
    • 3.2.2.2. Lack of Awareness
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Veterinary Endocrinology Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory & Reimbursement Framework
  • 3.3.4. Pricing Analysis, 2023
  • 3.3.5. Estimated Animal Population, by Key Species & key countries, 2023
  • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Veterinary Endocrinology Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Veterinary Endocrinology Market: Animal Type Movement Analysis
• 4.3. Global Veterinary Endocrinology Market Size & Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
• 4.4. Dogs
  • 4.4.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Cats
  • 4.5.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Other Animals
  • 4.6.1. Other Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Endocrinology Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Veterinary Endocrinology Market: Application Movement Analysis
• 5.3. Global Veterinary Endocrinology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.3.1. Pancreatic Disorders
    • 5.3.1.1. Pancreatic Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Other Disorders
    • 5.3.2.1. Other Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Endocrinology Market: Route of Administration Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Veterinary Endocrinology Market: Route of Administration Movement Analysis
• 6.3. Global Veterinary Endocrinology Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.3.1. Oral
    • 6.3.1.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Other Routes
    • 6.3.2.1. Other Routes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Endocrinology Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Veterinary Endocrinology Market Share, By Region, 2023 & 2030 (USD Million)
• 7.3. Regional Outlook
• 7.4. North America
  • 7.4.1. North America Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. U.S. Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Canada Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Mexico Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. UK Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Germany Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. France Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Italy Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Spain Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Denmark Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Sweden Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Norway Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Japan Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. China Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. India Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Australia Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. South Korea Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Thailand Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Brazil Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Argentina Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. South Africa Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Saudi Arabia Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. UAE Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Kuwait Veterinary Endocrinology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Company Market Position Analysis/ Heap Map Analysis
• 8.3. Company Profiles
  • 8.3.1. Dechra Pharmaceuticals PLC
    • 8.3.1.1. Participant's Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Elanco
    • 8.3.2.1. Participant's Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Merck & Co., Inc.
    • 8.3.3.1. Participant's Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Boehringer Ingelheim
    • 8.3.4.1. Participant's Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Zoetis
    • 8.3.5.1. Participant's Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. LLOYD, Inc.
    • 8.3.6.1. Participant's Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
• 8.4. Strategy Mapping
  • 8.4.1. Mergers & Acquisitions
  • 8.4.2. Partnerships & Collaborations
  • 8.4.3. Expansion
  • 8.4.4. Others
• 8.5. List of Other Key Players